bêta
IA Trial Radar
L'essai clinique NCT06245538 (ExStress) pour Adultes en bonne santé, Adults with Stress-related Symptoms est terminé. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici.
Un essai clinique correspond aux filtres sélectionnés
Vue en carte

Exercise Intensity on Brain & Mental Health in Stress (ExStress)

Terminé
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'essai' pour voir et discuter des informations sur l'essai dans la langue sélectionnée.
L'étude clinique NCT06245538 (ExStress) a été un essai interventionnel pour Adultes en bonne santé, Adults with Stress-related Symptoms. Son statut actuel est : terminé. L'étude a commencé le 15 février 2024, avec un objectif de recruter 24 participants. Dirigé par The Swedish School of Sport and Health Sciences, l'essai s'est terminé le 21 octobre 2025. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 2 décembre 2025.
Résumé succinct
This study aims to examine the role of exercise intensity in the acute effects of a single bout of aerobic exercise on neurotrophic factors, biomarkers of stress and inflammation, working memory task-related changes in prefrontal cortex oxygenation in adults with sub-clinical levels of stress-related symptoms.
Description détaillée
This study initially set out to include 43 adult (20 - 40 years) participants experiencing stress-related symptoms and 43 healthy controls, matched by age, sex, and fitness. These procedures were approved by the Swedish Ethical Review Autority (Approval number 2022-07297-01 and 2023-08181-02). Due to recruitment difficulties the design was later changed to include all individuals with sub-clinical stress symptoms and using stress as a covariate instead of comparing groups of healthy and stressed individuals (Ethical review approval number 2025-01786-02). This is a randomized-order crossover experimental trial with three experimental conditions separated by a wash-out period of 7 days: 20-min leg cycling exercise at moderate intensity, 20-min leg cycling exercise at vigorous intensity, and 20-min seated rest (passive control condition).

Prior to entering the study, study inclusion/exclusion criteria will be controlled using digital screening. Before the experimental sessions, all participants will complete two introductory study visits. At the first introductory visit, the participant's maximal oxygen uptake (VO2max) will be determined using a fitness test. This information will be used to determine the individual workloads (% of individual VO2max) that the participant will be cycling at during the experimental session. At the second introductory visit, participants will complete a familiarization session, in which key methodological aspects of the study will be introduced to participants. Participants' augmentation index, as a measure of arterial stiffness, will also be completed during this visit.

In each of the three experimental sessions, participants will perform a computerized working memory task (n-back task) pre- and post-exercise (or seated rest). During the working memory task, functional near-infrared spectroscopy (fNIRS) will be used to measure task-related changes in prefrontal cortex oxygenation. As such, each participant will complete six fNIRS measurements, two measurements (pre, post) for each of the three experimental sessions (moderate, high, control). Simultaneous with the fNIRS measurements, blood flow velocity in the left and right middle cerebral artery will be assessed during the n-back tasks using Transcranial Doppler ultrasound. At each experimental session, blood will also be sampled from the antecubital vein at six time points: pre the first n-back task, pre and post the cycling exercise (or seated rest), pre and post the second n-back task, and post the final 10-min seated rest. Whole blood samples will be assessed for blood gases, acid-base status, electrolytes, hematocrit level, platelet count, and glucose. The separated blood plasma and serum samples will be used for measurements of neurotrophic factors, lactate, biomarkers of stress and inflammation, and factors involved in blood glucose control. Blood samples will also be used for targeted DNA screening for alleles of the BDNF.

Additionally, the participant's current mood, mental and physical fatigue, heart rate variability (HRV) and blood pressure will be assessed during four 10-min seated rest periods: pre and post n-back, and pre and post cycling exercise (or seated rest). Prior to each experimental study session, participants will have assessments of sleep quality the night before, current health status, physical activity level during the week prior to the test day, sleepiness level the last 10 min, and current mood. Participant's sleep quality and heart rate variability during the night before and after each experimental session will also be assessed.

A release of an updated version of this study was attempted prior to completion of the study on October 3 2025, but due to a shutdown of the US goverment this was not possible to register until in November 24 2025.

Titre officiel

Acute Effects of Physical Exercise of Different Intensities on Biological and Psychological Outcomes Under Subclinical Stress and in Health

Conditions
Adultes en bonne santéAdults with Stress-related Symptoms
Autres identifiants de l'essai
  • ExStress
  • 2022-07297-01
  • 2023-08181-02 (Autre Identifiant) (Swedish ethical review authority)
Numéro NCT
Date de début (réel)
2024-02-15
Dernière mise à jour publiée
2025-12-02
Date de fin (estimée)
2025-10-21
Inscription (estimée)
24
Type d'essai
Interventionnel
PHASE
N/A
Statut
Terminé
Mots clés
FNIRS
Neuroplasticity
Neuroinflammation
cerebral blood flow
Exercise intensity
Psychological stress
Objectif principal
Prévention
Plan d'attribution
Randomisé
Modèle d'intervention
Croisé
Masquage
Aucun (ouvert)
Bras / Interventions
Groupe de participants/BrasIntervention/Traitement
ExpérimentalSeated rest
Participants will be resting while seated on a comfortable chair for 20 minutes
Seated Rest
Participants will be resting while seated on a comfortable chair for 20 minutes
ExpérimentalExercise at moderate intensity
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at moderate intensity (60% of VO2max)
Exercise at Moderate Intensity
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at moderate intensity (60% of VO2max)
ExpérimentalExercise at vigorous intensity
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at vigorous intensity (80% of VO2max)
Exercise at Vigorous Intensity
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at vigorous intensity (80% of VO2max)
Critère principal d'évaluation
Critères d'évaluationDescription de critèresPériode
Changes in cerebral blood flow in prefrontal cortex
working memory task-related changes in prefrontal cortex oxygenation measured using functional near-infrared spectroscopy
from before to after 20 minutes of exercise or seated rest
Critère secondaire d'évaluation
Critères d'évaluationDescription de critèresPériode
Brain-derived neurotrophic factor
pro and mature BDNF in blood sample taken from the forearm antecubital vein; concentrations measured in blood plasma and serum
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Working memory performance
computerized working memory task (n-back: 1-, 2- and 3-back)
At one time point before and one time point after 20 minutes of exercise or seated rest (In total over 1 hour)
DNA allele of brain-derived neurotrophic factor
in blood sample taken before intervention from the forearm antecubital vein
At one time point at baseline
Platelet count
in blood sample taken from the forearm antecubital vein
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Cortisol
biomarker of stress; in blood sample taken from the forearm antecubital vein
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Epinephrine
biomarker of stress; in blood sample taken from the forearm antecubital vein
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Norepinephrine
biomarker of stress; in blood sample taken from the forearm antecubital vein
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
C-reactive protein (CRP)
as a measure of systemic inflammation; in blood sample taken from the forearm antecubital vein
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Interleukin 6 (IL-6)
as a measure of systemic inflammation; in blood sample taken from the forearm antecubital vein
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Tumor necrosis factor alpha (TNF-α)
as a measure of systemic inflammation; in blood sample taken from the forearm antecubital vein
At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Mood
measured with a short version of Positive and Negative Affect Schedule (PANAS-SF) that include 5 positive and 5 negative affect states; the scoring scale is from 1 (very slightly or not at all) to 5 (extremely)
At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Mental fatigue
measured using Visual Analogue Scale (VAS-F); scoring scale: a line with 100 mm in length with scores falling between 0 mm (extremely alert) and 100 mm (extremely tired)
At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Physical fatigue
measured using Borg Rating of Perceived Exertion scale; scoring scale: from 6 (no exertion) to 20 (maximal exertion)
At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Sleep quality
measured using a Single-Item Sleep Quality Scale; scoring scale is from 0 (terrible) to 10 (excellent)
Over the night before and the night after each experimental session (In total over 36 hours)
Sleepiness
measured using Karolinska Sleepiness Scale; scoring scale is from 1 (extremely alert) to 9 (extremely sleepy)
At single time point before 20 minutes of exercise or seated rest
Heart rate variability
as an additional indicator of stress-related symptoms; measured with heart rate sensor and monitor
Over the night before and the night after each experimental session (In total over 36 hours)
Augmentation index
as a measure of arterial stiffness and indicator of cardiovascular health
At a single time point at baseline
Critères d'éligibilité

Âges éligibles
Adulte
Âge minimum
20 Years
Sexes éligibles
Tous
Accepte les volontaires en bonne santé
Oui

Participants experiencing sub-clinical levels of stress-related symptoms:

  • Age: 20-40 years
  • Absence of contraindications to physical exercise
  • Do not participate in any other study
  • Total score on the self-assessment scale 4-factor Shirom-Melamed Burnout Measure-19 lower than or equal to 4.00

  • Medical contraindication to catheterization of the antecubital vein and blood sampling
  • Dementia
  • Alcohol abuse
  • Smoking
  • Chronic medication that is considered to affect study outcomes
  • Chronic disease/syndrome such as migraine, fibromyalgia, chronic fatigue syndrome, bipolar syndrome, high blood pressure, cardiovascular disease, chronic obstructive pulmonary disease (COPD) or other lung disease
  • Post-COVID
  • Other somatic diseases, disorders, or injuries that may affect the physical ability during physical exercise
The Swedish School of Sport and Health Sciences logoThe Swedish School of Sport and Health Sciences
  • 🧬The Knowledge Foundation
  • 🏛️Avonova
  • 🏛️SATS
  • 🏛️Itrim
Partie responsable de l'essai
Maria Ekblom, Investigateur principal, Professor, The Swedish School of Sport and Health Sciences
Aucune donnée de contact disponible
1 Centres de l'essai dans 1 pays
The Swedish School of Sport and Health Sciences, Stockholm, 11433, Sweden